Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02181725
Other study ID # NL47323.068.13/METC13-3-062
Secondary ID 1202-068
Status Completed
Phase N/A
First received
Last updated
Start date July 2014
Est. completion date January 2018

Study information

Verified date June 2018
Source Maastricht University Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate whether a multimodal rehabilitation program effectively reduces functional disability in adolescents with chronic musculoskeletal pain, compared to care as usual.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date January 2018
Est. primary completion date January 2018
Accepts healthy volunteers No
Gender All
Age group 12 Years to 21 Years
Eligibility Inclusion Criteria:

- Age 12-21 years at the start of the study

- Complaints of chronic non-specific musculoskeletal pain of a duration > 3 months

- Considerable activity limitations

- Fear of movement

- Indication for outpatient multidisciplinary rehabilitation treatment

- Adequate Dutch literacy to complete the assessments (which mainly comprise questionnaires)

Exclusion Criteria:

- Any suspicion of a medical (orthopaedic, rheumatic or neurological) disease, that can explain the current pain complaints

- Any suspicion of an (underlying) psychiatric disease, for which psychiatric treatment is better suited, according to the expert opinion of the consultant in rehabilitation medicine.

- Pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Multimodal Rehabilitation Program
The Multimodal Rehabilitation Program is a Graded exposure based treatment. It consists of a Graded Exposure Module (GE), a Combination Module (HMGE) and a Parent Module (PM).
Care as Usual
Care as usual is the care currently provided to adolescents with musculoskeletal chronic pain and is based on the principles of Graded Activity.

Locations

Country Name City State
Netherlands Revant Revalidatiecentrum Breda Breda Noord Brabant
Netherlands Maastricht University Medical Center Maastricht Limburg
Netherlands Laurentius Ziekenhuis Roermond Roermond Limburg
Netherlands Rijndam Revalidatiecentrum Rotterdam Zuid Holland

Sponsors (4)

Lead Sponsor Collaborator
Maastricht University Medical Center Adelante, Centre of Expertise in Rehabilitation and Audiology, Fonds NutsOhra, Stichting Vooruit

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Functional Disability Adolescent self-reported functional disability Baseline, 8 weeks, 16 weeks, 10 months, 12 months
Secondary Change in Quality of life Adolescent self-reported pain-specific quality of life Baseline, 8 weeks, 16 weeks, 10 months, 12 months
Secondary Change in Fear of Pain Adolescent self-reported fear of pain Baseline, 8 weeks, 16 weeks, 10 months, 12 months
Secondary Change in Fear of Pain Parent proxy report measure Baseline, 8 weeks, 16 weeks, 10 months, 12 months
Secondary Change in Pain Catastrophizing Adolescent self-reported pain catastrophizing Baseline, 8 weeks, 16 weeks, 10 months, 12 months
Secondary Change in Pain Catastrophizing Parental catastrophizing about their child's pain Baseline, 8 weeks, 16 weeks, 10 months, 12 months
Secondary Change in Depressive symptoms Adolescent self-reported depressive symptoms Baseline, 8 weeks, 16 weeks, 10 months, 12 months
Secondary Change in Perceived Harmfulness Adolescent self-reported perceived harmfulness of daily activities Baseline, 8 weeks, 16 weeks, 10 months, 12 months
Secondary Change in Pain Intensity Adolescent self-reported pain intensity Baseline, 8 weeks, 16 weeks, 10 months, 12 months
Secondary Change in Functional Disability Parent-perceived functional disability of their child Baseline, 8 weeks, 16 weeks, 10 months, 12 months
Secondary Change in parental responses to childrens pain Baseline, 8 weeks, 16 weeks, 10 months, 12 months
Secondary Treatment expectations Adolescent self-report Baseline
Secondary Treatment expectations Parent self-report Baseline
Secondary Treatment satisfaction/ patient centeredness 16 weeks
Secondary Treatment satisfaction/ family centeredness 16 weeks
Secondary Change in General Health Related Quality of Life Baseline, 8 weeks, 16 weeks, 10 months, 12 months
Secondary Cost-diary per month Adolescent self-report of total health care utilization and other costs Baseline, 8 weeks, 16 weeks, 10 months, 12 months
Secondary Cost-diary per month Parent self-reported adolescent related costs Baseline, 8 weeks, 16 weeks, 10 months, 12 months
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain